Zang, Xingxing

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., et al. (2003) · Nature Immunology

T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

Cited by 883

Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy

Picarda, E., Ohaegbulam, K. C., & Zang, X. (2016) · Clinical Cancer Research

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 582

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

Zang, X., Thompson, R. H., Al-Ahmadie, H. A., Serio, A. M., Reuter, V. E., Eastham, J. A., Scardino, P. T., Sharma, P., & Allison, J. P. (2007) · Proceedings of the National Academy of Sciences

Prostate Cancer Treatment and ResearchCancer Immunotherapy and Biomarkers

Cited by 401

Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection

Loke, P., Gallagher, I., Nair, M. G., Zang, X., Brombacher, F., Mohrs, M., Allison, J. P., & Allen, J. E. (2007) · The Journal of Immunology

Immune cells in cancerPhagocytosis and Immune Regulation

Cited by 274

Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma

Koirala, P., Roth, M. E., Gill, J., Piperdi, S., Chinai, J. M., Geller, D. S., Hoang, B. H., Park, A., Fremed, M. A., Zang, X., et al. (2016) · Scientific Reports

Sarcoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 267

Homologues of Human Macrophage Migration Inhibitory Factor from a Parasitic Nematode

Zang, X., Taylor, P., Wang, J. M., Meyer, D. J., Scott, A. L., Walkinshaw, M. D., & Maizels, R. M. (2002) · Journal of Biological Chemistry

Macrophage Migration Inhibitory FactorParasites and Host Interactions

Cited by 108

HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival

Koirala, P., Roth, M. E., Gill, J., Chinai, J. M., Ewart, M. R., Piperdi, S., Geller, D. S., Hoang, B. H., Fatakhova, Y. V., Ghorpade, M., et al. (2016) · Scientific Reports

Sarcoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 100

Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFα

Akhmetzyanova, I., Aaron, T., Galbo, P., Tikhonova, A., Dolgalev, I., Tanaka, M., Aifantis, I., Zheng, D., Zang, X., & Fooksman, D. (2021) · Blood Advances

Multiple Myeloma Research and TreatmentsImmune cells in cancer

Cited by 39